Table 5 Comparative pharmacokinetic characteristics of Eperisone 150 mg after administration of immediate release conventional tablets (Reference) and osmotic pump dosage form (Test) in 12 healthy human subjects with geometric mean ratio and 90% CIs.

From: Comparative pharmacokinetics of osmotic-controlled and immediate-release Eperisone tablet formulation in healthy human subjects using a sensitive plasma LC-ESI-MS/MS method

Type of dosage Form

 

Cmax (ng/ml)

Tmax (hr)

AUC0-t (h.ng/ml)

AUC0-∞ (h.ng/ml)

t1/2ʎz (h)

Vz/F (L)

Cl/F (L/h)

MTT (h)

Immediate release (Reference = R)

Mean

7.65

1.02

20.67

20.88

1.81

18800

7211

2.94

SD

1.28

0.24

1.32

1.33

0.09

1690

450

0.26

%CV

16.78

23.36

6.4

6.38

5.14

8.99

6.24

8.91

Min

5.8

0.75

18.69

18.96

1.67

16815

6361

2.56

Max.

9.95

1.5

23.34

23.58

1.99

22755

7911

3.39

Osmotic pump (Test = T)

Mean

3.46

4.83

22.85

22.91

1.99

18982

6585

7.24

SD

0.33

1.21

1.67

1.67

0.15

2491

522

0.42

%CV

9.49

25.1

7.32

7.29

7.57

13.12

7.93

5.86

Min

2.95

3

19.32

19.39

1.69

15054

5948

6.51

Max.

4.01

6

25.17

25.22

2.17

24100

7735

7.78

Geometric Mean Ratio(T/R)

0.46

4.69

1.1

1.08

1.1

0.91

1

2.47

90% CI

0.41–0.51

3.74–5.89

1.05–1.16

1.03–1.14

1.04–1.16

0.85–0.98

0.90–1.12

2.36–2.59